Resources and Information

»Clinical Guidelines

Oct 16 2018

CyPass Clinical Recommendations

J. James Thimons, OD, FAAO

ASCRS (American Society of Cataract and Refractive Surgery) has released information related to the CyPass Stent and its recall.
read more

discuss

 

»Industry News

Aug 29 2018

Alcon Withdraws CyPass Stents

J. James Thimons, OD, FAAO

Alcon announces a voluntary withdrawal of all CyPass stents.
read more

discuss

 

»Glaucoma Watch

Aug 08 2018

DREAM Study

Bud O'Leary, OD

The DREAM study of dry eye was discussed as part of a lecture at the National Glaucoma Symposium. However, the NIH-funded study has received some criticism for the conclusion about the effectiveness of omega-3 supplements versus olive oil as the placebo.
read more

discuss

 

»Glaucoma Watch

Aug 08 2018

National Glaucoma Symposium 2018

Janet Swartz, EdD

The 15th annual National Glaucoma Symposium took place at the Ocean Edge Resort on July 28-30, 2018 and was another great program. Many of the doctors return each year to this premier conference for the high-quality lectures, informal and collegial atmosphere, and beautiful location.
read more

discuss

 

»Industry News

Jul 02 2018

Glaukos iStent inject FDA Approved

J. James Thimons, OD, FAAO

I was just contacted by Glaukos with the exciting news of the FDA approval of their newest glaucoma MIGS device, the iStent inject.
read more

discuss

 

»Case of the Month

Jun 22 2018

Doyne's Honeycomb Dystrophy

Bud O'Leary, OD

Dr. Brad Sutton discusses the use of an OCT to quantify drusen in macular degeneration and presents OCT scans for Doyne's Honeycomb Dystrophy.
read more: Full Members Only

 

»Webinars

Jun 21 2018

Influences on IOP

Janet Swartz, EdD

Dr. Leo Semes discusses the role of elevated IOP in glaucoma and describes the factors that affect IOP.
read more: Full Members Only

 

»Case of the Month

May 14 2018

Central Serous Retinopathy

Bud O'Leary, OD

Dr. Blair Lonsberry presents a patient with a visual field defect and describes the diagnosis and treatment of central serous retinopathy.
read more: Full Members Only

 

 

previous    next